Eric F. Johnson
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
- PARP inhibition in cancer therapy
Papers in
- Pharmacology 15
- Pharmacogenetics and Drug Metabolism 14
- Oncology 42
- PARP inhibition in cancer therapy 18
- Cancer-related Molecular Pathways 7
- Co-authors
- Douglas C. ReesOded LewinsonRonald W. EstabrookF. Peter GuengerichDaniel W. NebertFrank J. GonzalezI. C. GunsalusRyo Sato
- Journals
- Bioorganic & Medicinal Chemistry Letters (19 papers)Journal of Biological Chemistry (12 papers)Biochemistry (6 papers)Journal of Medicinal Chemistry (5 papers)Molecular Cancer Research (4 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Eric F. Johnson
148 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Pharmacology 2.0k
- Oncology 3.0k
- Molecular Biology 5.1k
- Biochemistry 462
- Cancer Research 610
Countries citing papers authored by Eric F. Johnson
This map shows the geographic impact of Eric F. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric F. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric F. Johnson more than expected).
Fields of papers citing papers by Eric F. Johnson
This network shows the impact of papers produced by Eric F. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric F. Johnson. The network helps show where Eric F. Johnson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric F. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 7 | |
| 3 | 2019 | 21 | |
| 4 | 2018 | 173 | |
| 5 | 2017 | 1 | |
| 6 | 2016 | 6 | |
| 7 | 2015 | 198 | |
| 8 | Eye Sun Protection Factor (ESPF): A New Index that Considers Spectacle Lens Coating, Curvature, Configuration, and Coverage | 2012 | 1 |
| 9 | 2009 | 77 | |
| 10 | ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor Hit paper breakdown → | 2008 | 1513 |
| 11 | 2008 | 178 | |
| 12 | 2007 | 1 | |
| 13 | 2003 | 5 | |
| 14 | 2001 | 63 | |
| 15 | Let's Hear It for Learning. | 2001 | 2 |
| 16 | Inka Bodies and the Body of Christ: Corpus Christi in Colonial Cuzco, Peru (review) | 2000 | 1 |
| 17 | 1995 | 2 | |
| 18 | 1991 | 6 | |
| 19 | The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Loci Hit paper breakdown → | 1989 | 521 |
| 20 | The P450 Gene Superfamily: Recommended Nomenclature Hit paper breakdown → | 1987 | 657 |
About Eric F. Johnson
Eric F. Johnson is a scholar working on Pharmacology, Oncology, Biochemistry, Molecular Biology and Mechanics of Materials, having authored 154 papers that have together received 9.9k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (18 papers), Pharmacogenetics and Drug Metabolism (14 papers), Mechanical Behavior of Composites (14 papers), DNA Repair Mechanisms (12 papers), Biochemical and Molecular Research (9 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Pharmacology (2.0k citations), Oncology (3.0k citations), Molecular Biology (5.1k citations), Biochemistry (462 citations) and Cancer Research (610 citations). Eric F. Johnson has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Douglas C. Rees, Oded Lewinson, Ronald W. Estabrook, F. Peter Guengerich, Daniel W. Nebert, Frank J. Gonzalez, I. C. Gunsalus, Ryo Sato, Minor J. Coon and Michael R. Waterman. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, Biochemistry, Journal of Medicinal Chemistry and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.